MiR-145-5p appears to play a key role as a tumor suppressor by targeting N-cadherin and its downstream effector matrix metalloproteinase-9 (MMP9), and it is the most frequently reported downregulated miRNA in BC. The gene discussed is MMP9; the disease is breast cancer.